Home | Welcome to Contract Pharma   
Last Updated Wednesday, April 1 2015

Print

Topics - Drug Development


Refine by Date:
From: To:
Published April 1, 2015
Investment by ICF is its first in a US pharma company Read More »
Published April 1, 2015
Asubio's projects will be integrated into the Daiichi Sankyo's global development organization Read More »
Published March 31, 2015
To supply 14C radiolabelled drug products to specialist oncology clinics Read More »
Published March 31, 2015
Enhances capabilities and services in UT, NJ, KS and Russia Read More »
Published March 31, 2015
Will support manufacture of BCX4430 for trials Read More »
Published March 30, 2015
Expands orphan business unit with RAVICTI and BUPHENYL Read More »
Published March 30, 2015
Expands CNS franchise Read More »
Published March 30, 2015
Merck Serono gains access to Intrexon's suite of technologies to engineer T-cells Read More »
Published March 27, 2015
Will use RXi's self-delivering RNAi technology to develop cell-based immunotherapies to treat cancer Read More »
Published March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments Read More »
Published March 26, 2015
Yordon retires, Kung to serve as chairman Read More »
Published March 26, 2015
Combined service offering aims to speed drug development and reduce costs Read More »
Published March 25, 2015
Will evaluate the safety, tolerability and pharmacokinetics in advanced liver cancer Read More »
Published March 25, 2015
Will receive as much as ÂŁ652,000 to expand bioproduction research Read More »
Published March 25, 2015
Triggers $7 million BARDA milestone Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On